To further demonstrate whether C1q regulated NPC cells through PI3K‐AKT signaling, AKT‐deficient tumor cells were established using the CRISPR‐Cas9 system (Figure S5A, Supporting Information). This evidence concerns the gene AKT1 and nasopharyngeal carcinoma.